Arvelle Therapeutics
Founded Year
2019Stage
Acquired | AcquiredTotal Raised
$207.8MValuation
$0000Missing: Arvelle Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Arvelle Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Arvelle Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Arvelle Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Latest Arvelle Therapeutics News
Nov 15, 2021
Switzerland-based Arvelle Therapeutics, which was acquired by Italy’s Angelini earlier this year, today… To continue reading The Pharma Letter please login , subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. Or, if you're only interested in reading the content about a specific topic (M&A, coronavirus/COVID-19, pricing, reimbursement and access, outsourcing, CRO and CMO, and regulation), then you can take our £10 per month channel subscription offer, which gives you access to all our news articles and in-depth content on this subject.
Arvelle Therapeutics Frequently Asked Questions (FAQ)
When was Arvelle Therapeutics founded?
Arvelle Therapeutics was founded in 2019.
Where is Arvelle Therapeutics's headquarters?
Arvelle Therapeutics's headquarters is located at Zählerweg 6, Zug.
What is Arvelle Therapeutics's latest funding round?
Arvelle Therapeutics's latest funding round is Acquired.
How much did Arvelle Therapeutics raise?
Arvelle Therapeutics raised a total of $207.8M.
Who are the investors of Arvelle Therapeutics?
Investors of Arvelle Therapeutics include Angelini Pharma, EQT Life Sciences, Andera Partners, QHP Capital, H.I.G. BioHealth Partners and 6 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.